Pharmaceutical news | ELSI Avocats

Filter by

Medical device law

Legacy devices and MDR - Are you compliant? Analysis of the MDCG 2021-25

Some devices that are CE marked according to one of the MD or AIMD directives can still be marketed after the date of application of the regulation.

Digital & E-health

Repository on the processing of personal data for the purpose of creating data warehouses in the field of health

The CNIL adopted by deliberation n° 2021-118 of 7 October 2021 (JORF 24 October 2021) a new reference framework aiming to "simplify the procedures".

Pharmaceutical law

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

The Council of State refers to the Constitutional Council the question of the conformity of the narcotics regulations on cannabis...

Pharmaceutical law

Procedures for transmitting to the CEPS the amount of public investment in research and development

Since 2021, the amount of public R&D investment from which companies exploiting certain medicines have benefited is made available

Medical device law

New reporting obligation for companies marketing at least one health product listed on the LPPR

Since 2021, a declaration of sales prices (net of discounts or taxes) must be made by operators or suppliers...

Medical device law

Entry into force of Regulation 2017/745 on medical devices (MDR): update on clinical evaluation

Regulation 2017/745 on medical devices (MDR) came into force on 26 May 2021 with the notable aim of evolving...

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Newsletter subscription

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

NEWS

Obligations of medical device (MD) distributors: clarification of their scope before the CJEU

Legacy devices and MDR - Are you compliant? Analysis of the MDCG 2021-25

Repository on the processing of personal data for the purpose of creating data warehouses in the field of health

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Procedures for transmitting to the CEPS the amount of public investment in research and development

New reporting obligation for companies marketing at least one health product listed on the LPPR

Entry into force of Regulation 2017/745 on medical devices (MDR): update on clinical evaluation

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

NEWS

Obligations of medical device (MD) distributors: clarification of their scope before the CJEU

Legacy devices and MDR - Are you compliant? Analysis of the MDCG 2021-25

Repository on the processing of personal data for the purpose of creating data warehouses in the field of health

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Procedures for transmitting to the CEPS the amount of public investment in research and development

New reporting obligation for companies marketing at least one health product listed on the LPPR

Entry into force of Regulation 2017/745 on medical devices (MDR): update on clinical evaluation

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

SUBSCRIBE TO OUR NEWSLETTER!